Laura Muinelo-Romay
Overview
Explore the profile of Laura Muinelo-Romay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
1521
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Casas-Arozamena C, Vilar A, Cueva J, Arias E, Sampayo V, Diaz E, et al.
J Exp Clin Cancer Res
. 2024 Sep;
43(1):264.
PMID: 39304963
Background: There has been a rise in endometrial cancer (EC) incidence leading to increased mortality. To counter this trend, improving the stratification of post-surgery recurrence risk and anticipating disease relapse...
2.
Mondelo-Macia P, Garcia-Gonzalez J, Leon-Mateos L, Abalo A, Bravo S, Chantada Vazquez M, et al.
Mol Cell Proteomics
. 2024 Aug;
23(10):100834.
PMID: 39216661
Immunotherapy has improved survival rates in patients with cancer, but identifying those who will respond to treatment remains a challenge. Advances in proteomic technologies have enabled the identification and quantification...
3.
Lopez-Cortes R, Muinelo-Romay L, Fernandez-Briera A, Gil Martin E
J Proteome Res
. 2024 Mar;
23(4):1379-1398.
PMID: 38507902
Disruption of the glycosylation machinery is a common feature in many types of cancer, and colorectal cancer (CRC) is no exception. Core fucosylation is mediated by the enzyme fucosyltransferase 8...
4.
Pereira-Veiga T, Behrens B, Broekmaat J, Oomens L, Stevens M, Tibbe A, et al.
Methods Mol Biol
. 2024 Jan;
2752:65-70.
PMID: 38194028
Tumor heterogeneity has a major role in the development of tumor evasion and resistance to treatments. To study and understand the intrinsic heterogeneity of cancer cells, the use of single-cell...
5.
Bao-Caamano A, Costa-Fraga N, Cayrefourcq L, Rodriguez-Casanova A, Muinelo-Romay L, Lopez-Lopez R, et al.
Front Cell Dev Biol
. 2024 Jan;
11:1291179.
PMID: 38188020
Therapy resistance is a major challenge in colorectal cancer management. Epigenetic changes, such as DNA methylation, in tumor cells are involved in the development of acquired resistance during treatment. Here,...
6.
Bao-Caamano A, Costa-Fraga N, Cayrefourcq L, Jacome M, Rodriguez-Casanova A, Muinelo-Romay L, et al.
Sci Rep
. 2023 Oct;
13(1):16999.
PMID: 37813898
No abstract available.
7.
Bao-Caamano A, Costa-Fraga N, Cayrefourcq L, Jacome M, Rodriguez-Casanova A, Muinelo-Romay L, et al.
Sci Rep
. 2023 Sep;
13(1):15401.
PMID: 37717096
Circulating tumor cells (CTCs) and epigenetic alterations are involved in the development of metastasis from solid tumors, such as colorectal cancer (CRC). The aim of this study was to characterize...
8.
Arias-Diaz A, Ferreiro-Pantin M, Barbazan J, Perez-Beliz E, Ruiz-Banobre J, Casas-Arozamena C, et al.
Int J Mol Sci
. 2023 Sep;
24(17).
PMID: 37686015
Gynaecological serous carcinomas (GSCs) constitute a distinctive entity among female tumours characterised by a very poor prognosis. In addition to late-stage diagnosis and a high rate of recurrent disease associated...
9.
Lopez-Cortes R, Correa Pardo I, Muinelo-Romay L, Fernandez-Briera A, Gil-Martin E
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569254
Epithelial cells can undergo apoptosis by manipulating the balance between pro-survival and apoptotic signals. In this work, we show that TRAIL-induced apoptosis can be differentially regulated by the expression of...
10.
Brozos-Vazquez E, Lago-Leston R, Covela M, de la Camara Gomez J, Fernandez-Montes A, Candamio S, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509239
We aimed to identify common mCRC profiles associated with a discordant mutational status of between the standard of care (SoC) tumour tissue tests and ctDNA tests to understand ctDNA detection...